UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

The Friends of Cancer Research Real‐World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies

Clinical pharmacology and therapeutics, 2022-01, Vol.111 (1), p.283-292

2022

Volltextzugriff (PDF)

Real‐world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B‐cell lymphoma by line of therapy

Cancer medicine (Malden, MA), 2024-04, Vol.13 (7), p.e7173-n/a

2024

Volltextzugriff (PDF)

Real-world study of disease-free survival & patient characteristics associated with disease-free survival in early-stage non-small cell lung cancer: A retrospective observational study

Cancer treatment and research communications, 2023-01, Vol.36, p.100742-100742, Article 100742

2023

Volltextzugriff (PDF)

Use of Real-World Evidence in a Virtual Bridging Analysis for a Human Epidermal Growth Factor Receptor 2-Targeted Antibody-Drug Conjugate in Gastric Cancer

Journal of clinical pharmacology, 2023-11, Vol.63 (11), p.1244-1255

2023

Volltextzugriff (PDF)

Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease

American journal of respiratory and critical care medicine, 2015-03, Vol.191 (5), p.557-565

2015

Volltextzugriff (PDF)

Real-world outcomes of frontline venetoclax-based therapy in older adults with acute myeloid leukemia: an analysis utilizing EHR data

Leukemia & lymphoma, 2023-05, Vol.64 (6), p.1123-1128

2023

Volltextzugriff (PDF)

Real‐world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot

Clinical pharmacology and therapeutics, 2022-02, Vol.111 (2), p.444-454

2022

Volltextzugriff (PDF)

Reality check: Real-world evidence to support therapeutic development in hematologic malignancies

Blood reviews, 2022-05, Vol.53, p.100913-100913, Article 100913

2022

Volltextzugriff (PDF)

In-Home Air Pollution Is Linked to Respiratory Morbidity in Former Smokers with Chronic Obstructive Pulmonary Disease

American journal of respiratory and critical care medicine, 2013-05, Vol.187 (10), p.1085-1090

2013

Volltextzugriff (PDF)

Indoor particulate matter exposure is associated with increased black carbon content in airway macrophages of former smokers with COPD

Environmental research, 2016-10, Vol.150, p.398-402

2016

Volltextzugriff (PDF)

Respiratory Effects of Indoor Heat and the Interaction with Air Pollution in Chronic Obstructive Pulmonary Disease

Annals of the American Thoracic Society, 2016-12, Vol.13 (12), p.2125-2131

2016

Volltextzugriff (PDF)

Obesity as a susceptibility factor to indoor particulate matter health effects in COPD

The European respiratory journal, 2015-05, Vol.45 (5), p.1248-1257

2015

Volltextzugriff (PDF)

Indoor pollutant exposure is associated with heightened respiratory symptoms in atopic compared to non-atopic individuals with COPD

BMC pulmonary medicine, 2014-09, Vol.14 (1), p.147-147, Article 147

2014

Volltextzugriff (PDF)

Identification of Barriers of CAR-T Utilization in Patients with Diffuse Large B-Cell Lymphoma

Blood, 2021-11, Vol.138 (Supplement 1), p.1972-1972

2021

Volltextzugriff (PDF)

Evaluation of Functional and Cytogenetic High-Risk Multiple Myeloma Using Real-World Data

Blood, 2021-11, Vol.138 (Supplement 1), p.4093-4093

2021

Volltextzugriff (PDF)

Real-World First-Line Treatment and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Bruton Tyrosine Kinase Inhibitor (BTKi) or B-Cell Lymphoma 2 (BCL2) Therapy

Blood, 2022-11, Vol.140 (Supplement 1), p.4142-4143

2022

Volltextzugriff (PDF)

Assessing real-world clinical response in patients with multiple myeloma (MM): A survey of the literature

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19260-e19260

2020

Volltextzugriff (PDF)

Real-World Treatment Patterns and Outcomes of Patients with Functional High-Risk (Early Relapse) Multiple Myeloma

Blood, 2020-11, Vol.136 (Supplement 1), p.17-18

2020

Volltextzugriff (PDF)

Development of an Inclusive Risk Prognostic Index for Newly Diagnosed Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.3789-3789

2021

Volltextzugriff (PDF)

Frontline Venetoclax (ven) Based Combination Therapy in Older Adults with Acute Myeloid Leukemia Treated in the Real-World Setting; A Multi-Institutional Retrospective Study

Blood, 2021-11, Vol.138 (Supplement 1), p.4136-4136

2021

Volltextzugriff (PDF)

REALM (OP-RW001): Comparing the Characteristics and Clinical Outcomes of Patients with Relapsed/Refractory Multiple Myeloma in the Real World to Patients Receiving Melflufen in the Horizon Study

Blood, 2021-11, Vol.138 (Supplement 1), p.1967-1967

2021

Volltextzugriff (PDF)

Real-world treatment and outcomes of frontline chemotherapy in patients with metastatic pancreatic cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16249-e16249

2021

Volltextzugriff (PDF)

Real-world outcomes of patients with advanced non-small cell lung cancer and driver mutations treated with frontline immunotherapy and/or chemotherapy

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21156-e21156

2021

Volltextzugriff (PDF)

Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.6595-6595

2023

Volltextzugriff (PDF)

Real-World Treatment Patterns Among Patients with Newly-Diagnosed (ND)-Acute Myeloid Leukemia (AML) in the United States (US)

Blood, 2022-11, Vol.140 (Supplement 1), p.5100-5102

2022

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(78)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Friends of Cancer Research Real‐World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies

Real‐world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B‐cell lymphoma by line of therapy

Real-world study of disease-free survival & patient characteristics associated with disease-free survival in early-stage non-small cell lung cancer: A retrospective observational study

Use of Real-World Evidence in a Virtual Bridging Analysis for a Human Epidermal Growth Factor Receptor 2-Targeted Antibody-Drug Conjugate in Gastric Cancer

Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease

Real-world outcomes of frontline venetoclax-based therapy in older adults with acute myeloid leukemia: an analysis utilizing EHR data

Real‐world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot

Reality check: Real-world evidence to support therapeutic development in hematologic malignancies

In-Home Air Pollution Is Linked to Respiratory Morbidity in Former Smokers with Chronic Obstructive Pulmonary Disease

Indoor particulate matter exposure is associated with increased black carbon content in airway macrophages of former smokers with COPD

Respiratory Effects of Indoor Heat and the Interaction with Air Pollution in Chronic Obstructive Pulmonary Disease

Obesity as a susceptibility factor to indoor particulate matter health effects in COPD

Indoor pollutant exposure is associated with heightened respiratory symptoms in atopic compared to non-atopic individuals with COPD

Identification of Barriers of CAR-T Utilization in Patients with Diffuse Large B-Cell Lymphoma

Evaluation of Functional and Cytogenetic High-Risk Multiple Myeloma Using Real-World Data

Real-World First-Line Treatment and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Bruton Tyrosine Kinase Inhibitor (BTKi) or B-Cell Lymphoma 2 (BCL2) Therapy

Assessing real-world clinical response in patients with multiple myeloma (MM): A survey of the literature

Real-World Treatment Patterns and Outcomes of Patients with Functional High-Risk (Early Relapse) Multiple Myeloma

Development of an Inclusive Risk Prognostic Index for Newly Diagnosed Multiple Myeloma

Frontline Venetoclax (ven) Based Combination Therapy in Older Adults with Acute Myeloid Leukemia Treated in the Real-World Setting; A Multi-Institutional Retrospective Study

REALM (OP-RW001): Comparing the Characteristics and Clinical Outcomes of Patients with Relapsed/Refractory Multiple Myeloma in the Real World to Patients Receiving Melflufen in the Horizon Study

Real-world treatment and outcomes of frontline chemotherapy in patients with metastatic pancreatic cancer

Real-world outcomes of patients with advanced non-small cell lung cancer and driver mutations treated with frontline immunotherapy and/or chemotherapy

Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets

Real-World Treatment Patterns Among Patients with Newly-Diagnosed (ND)-Acute Myeloid Leukemia (AML) in the United States (US)

Suchergebnisse filtern